Saniona: Second Tesomet Phase IIb study Underway - Redeye
Redeye views the initiation of the Phase IIb study in Tesomet for Prader-Willi Syndrome (PWS) as another significant milestone for the company and we give an initial comment.
ANNONS
Redeye views the initiation of the Phase IIb study in Tesomet for Prader-Willi Syndrome (PWS) as another significant milestone for the company and we give an initial comment.